Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 5/20 | 0.68 |
| ▸ | MAPK8 | P45983 | 9/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.53 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13876222 | 0.86 | EPHX2 (0.59) | EPHX2MAPK8ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL4186327 | 0.80 | EPHX2 (0.75) | EPHX2SMN1; SMN2LMNAMAPK1NLRP1 | |
| SCHEMBL4187765 | 0.79 | EPHX2 (0.73) | EPHX2SMN1; SMN2LMNAMAPK1NLRP1 | |
| SCHEMBL14456735 | 0.78 | RAB9A (0.48) | EPHX2MAPK8ALDH1A1 | |
| SCHEMBL14576180 | 0.77 | MAPK8 (1.00) | MAPK8 | |
| SCHEMBL14575600 | 0.76 | MAPK8 (1.00) | MAPK8 | |
| SCHEMBL14617117 | 0.76 | MAPK8 (1.00) | MAPK8 | |
| SCHEMBL4197060 | 0.76 | EPHX2 (0.72) | EPHX2MAPK8LMNAMAPK1NLRP1 | |
| SCHEMBL13876233 | 0.75 | ALDH1A1 (0.51) | EPHX2MAPK8ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL4187168 | 0.75 | EPHX2 (0.74) | EPHX2LMNAMAPK1NLRP1ROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090099184-A1 | Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-04-16 | — | — | US | disclosed |
| US-20090099184-A1 | Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099184-A1 | Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors | EPHX1, EPHX2, NCEH1 | EPHX2 2/4885MAPK8 2623/4885ALDH1A1 310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.